Skip to content

ViewRay, Inc.

Delisted

CIK 1597313fmd_0F6BMQPK93Y88SA10R81KW2KXAManufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard

Coverage: Dec 01, 2012 to Mar 31, 2023, 43 periods

Income Statement · Annual · Millions · USD
Line itemFY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022
Total revenues3610223481885770102
Cost of revenue891526287493617092
Gross profit(5)(3)(4)(4)67(5)(4)010
Research and development991011151724253232
Selling, general and administrative13192729406592777283
Total operating expenses222937415482115102104117
Operating income(27)(32)(41)(44)(48)(75)(121)(106)(104)(107)
Interest expense0236784345
Interest and investment income0000002102
Other non-operating income (expense)(0)0(0)(1)(17)631(2)3
Income before taxes(27)(34)(45)(51)(72)(76)(120)(108)(110)(107)
Income tax expense0000000000
Net income from continuing operations(27)(34)(45)(51)(72)(76)(120)(108)(110)(107)
Net income(27)(34)(45)(51)(72)(76)(120)(108)(110)(107)
Net income to common shareholders(28)(34)(45)(51)––(120)(108)(110)(107)